Showing 61-70 of 3039 results for "".
Glaukos Submits NDA for Epi-On CLX Candidate
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-submits-nda-for-epi-on-clx-candidate/37066/Glaukos submits a new drug application to the FDA for its next-generation cross-linking therapy; Regeneron releases phase 3 results for Eylea HD for RVO; and Regeneron acquires a clinical stage biotech making ocular delivery technology for retinal disorders. Learn more about your ad choices. Visit mCorrecting High Myopia at the Nodal Point
https://modernod.com/mod-issues/2022-oct/correcting-high-myopia-at-the-nodal-point/39127/Redesigned with a central port, the latest version of the ICL is associated with better visual outcomes and less risk than earlier iterations of the lens.Alcon Gains FDA Approval for Novel DED Drug
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-gains-fda-approval-for-novel-ded-drug/37087/Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more abWhat to Do With Noncompliant Dry Eye Patients
https://modernod.com/podcasts/to-the-point/what-to-do-with-noncompliant-dry-eye-patients/36895/Do you have patients who find it difficult to stick with their dry eye treatment plans? In this episode of To the Point, Leslie and Jackie discuss how they have handled various noncompliant patient situations. The hosts also provide tips for increasing patient adherence to treatment plans and improvA Winding Path Leads to Career Satisfaction
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-oct-2022-video/37317/Joseph J. Allen, OD, FAAO, Dipl ABO, interviews Justin Manning, OD, MPH, FAAO, about his journey from optometric clinical practice to industry. The move to industry starts with building your network, and you can do this by engaging with sales representatives who visit your clinic and industry partneGlaucoma Suspect Identified: Now What?
https://modernod.com/topics/glaucoma/glaucoma-suspect-identified-now-what/38180/Testing, education, and follow-up are vital.Laser Therapy Then and Now
https://modernod.com/topics/retina/laser-therapy-then-and-now/37945/In the changing landscape of treatment options for diabetic eye disease, is there still a place for laser?Notes on Delivering a Difficult Diagnosis
https://modernod.com/topics/patient-care/notes-on-delivering-a-difficult-diagnosis/38675/Learn the importance of empathetic communication in discussing tough diagnoses and treatments with patients.Notal Vision Diagnostic Clinic—Your Practice’s Partner for Remote Patient Monitoring
https://modernod.com/mod-issues/2021-july-aug-insert3/notal-vision-diagnostic-clinic-your-practices-partner-for-remote-patient-monitoring-1/38283/New Practice, Noh Problem: Lessons From Opening a Cold Start Practice
https://modernod.com/podcasts/to-the-point/new-practice-noh-problem-lessons-from-opening-a-cold-start-practice/36932/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome this month’s guest, Ada Noh, OD. Dr. Noh shares her story of how she came to open her very own practice, dedicated solely to dry eye, in a brand new city. She talks about building up her patient base, networking with local prov